Substantial, sustained, portable funding
Today, it is not uncommon for researchers to spend a significant amount of their time writing grants. To us, this is time wasted. We want researchers to concentrate on chasing breakthroughs instead of chasing dollars. Through awards of up to $1.625 million, Pathway to Stop Diabetes® will allow scientists to explore their new or even radical ideas with confidence. And without having to annually apply or reapply for funding.
The Pathway program seeks to bring new investigators and new perspectives to diabetes research. Supporting scientists with different backgrounds and experience is critical to achieving that objective.
Candidates will be identified through nominations from U.S. accredited academic and non-profit research institutions. Pathway accepts nominations for exceptional investigators with medical and scientific backgrounds who propose innovative basic, clinical, translational, behavioral, epidemiological and health services research relevant to any type of diabetes, diabetes-related disease state or complication.
Pathway solicits nominations for candidates in all disciplines as applied to diabetes, from medicine, biology and chemistry to engineering, mathematics and physics. In addition, nomination of scientists from diverse backgrounds, including minority groups that are underrepresented in biomedical research, is strongly encouraged. The challenges of comparing different research approaches and investigators across a broad spectrum are met by assembling a diverse group of reviewers with content expertise that give careful consideration to all types of proposals during the review process.
Newly emerging scientists face numerous obstacles early in their careers, but none more daunting than securing the funding for their work to begin.
For post-doctoral talent on the cusp of their research careers, Initiator Awards provide the means to establish independent careers, hire staff and—most importantly—focus completely on conducting their innovative research.
The two-part funding is designed to support the transition from trainee to independent investigator.
Researchers pursuing high risk but promising projects often encounter difficulty in finding continuing financial support. This leads to delays in progress as resources are pulled away from research and applied to the search for funding.
For scientists early in their careers, Accelerator Awards provide the freedom to continue their work undistracted. This in turn will help to accelerate their research in novel areas that hold high promise for a breakthrough in the fight to Stop Diabetes.
Established, experienced investigators with strong records of outstanding productivity would have difficulty securing funding to apply their considerable skills and expertise to a new field.
For experienced investigators with demonstrated success in another field to bring their expertise to diabetes research for the first time, Visionary Awards provide support for particularly innovative and transformational ideas that have the potential to have an exceptional impact in diabetes.
Funding is granted in two phases, with transition to Phase 2 funding contingent on the success of Phase 1, as evidenced by productivity and continued dedication to diabetes research.
Additional grant opportunities
Pathway to Stop Diabetes is not for every researcher. The American Diabetes Association's Research Program offers additional grant opportunities that span the spectrum of diabetes research and supports investigators in all stages of their careers.
Visit professional.diabetes.org/grants-pathway to learn more.